QIPT vs. AIRS, VMD, TOI, DCGO, XGN, CORBF, EUDA, KDLY, BMGL, and ATPC
Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), Oncology Institute (TOI), DocGo (DCGO), Exagen (XGN), Global Cord Blood (CORBF), EUDA Health (EUDA), Kindly MD (KDLY), Basel Medical Group (BMGL), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry.
Quipt Home Medical vs. Its Competitors
Quipt Home Medical (NASDAQ:QIPT) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability, institutional ownership, dividends and risk.
Quipt Home Medical has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 2.47, suggesting that its share price is 147% more volatile than the S&P 500.
AirSculpt Technologies has lower revenue, but higher earnings than Quipt Home Medical. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Quipt Home Medical, indicating that it is currently the more affordable of the two stocks.
Quipt Home Medical has a net margin of -2.90% compared to AirSculpt Technologies' net margin of -4.13%. AirSculpt Technologies' return on equity of 2.22% beat Quipt Home Medical's return on equity.
42.8% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are owned by institutional investors. 13.4% of Quipt Home Medical shares are owned by company insiders. Comparatively, 76.6% of AirSculpt Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Quipt Home Medical received 21 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 80.00% of users gave Quipt Home Medical an outperform vote while only 35.48% of users gave AirSculpt Technologies an outperform vote.
Quipt Home Medical currently has a consensus target price of $2.85, indicating a potential upside of 34.43%. AirSculpt Technologies has a consensus target price of $3.75, indicating a potential downside of 26.61%. Given Quipt Home Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Quipt Home Medical is more favorable than AirSculpt Technologies.
In the previous week, Quipt Home Medical had 2 more articles in the media than AirSculpt Technologies. MarketBeat recorded 10 mentions for Quipt Home Medical and 8 mentions for AirSculpt Technologies. Quipt Home Medical's average media sentiment score of 0.34 beat AirSculpt Technologies' score of 0.15 indicating that Quipt Home Medical is being referred to more favorably in the media.
Summary
Quipt Home Medical beats AirSculpt Technologies on 12 of the 19 factors compared between the two stocks.
Get Quipt Home Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quipt Home Medical Competitors List
Related Companies and Tools
This page (NASDAQ:QIPT) was last updated on 6/12/2025 by MarketBeat.com Staff
Buy QIPT Stock Free QIPT Stock Alerts